Exceed ABT Acetabular Cup Cementless System

NCT04255394 | Completed Results

• 1 other identifier: BMETEU.CR.EU37
• Study Type: observational
• Target: 677
• Locations: 0 countries
• Sites: N/A

Brief Summary

A Post-market Clinical Follow-up Study to provide safety, performance and clinical benefits data on the Exceed ABT acetabular cup (implants and instruments) when used in combination with ceramic liners or polyethylene articulating liners bearing Options. A single-center, cohort observational clinical outcomes study

Conditions

Osteoarthritis; Rheumatoid Arthritis; Correction of Functional Deformity

Outcome Measures

Primary Outcomes (3)

• Harris Hip Score

  Clinical performance - as measured by clinical score data (HHS). The HHS was developed for the assessment of the results of hip surgery, and is intended to evaluate various hip disabilities and methods of treatment in an adult population. The domains covered are pain, function, absence of deformity, and range of motion. The score has a minimum of 0 and a maximum of 100 points. The scale: Excellent:90 - 100, Good: 80 - 89, Fair: 70 - 79, Poor: \< 70.

  10 years

• Western Ontario and McMasters Universities Osteoarthritis Index-WOMAC Pain Score

  Clinical performance - as measured by clinical score data - womac pain The Western Ontario and McMaster Universities Arthritis Index (WOMAC) is widely used in the evaluation of Hip and Knee Osteoarthritis. It is a self-administered questionnaire consisting of 24 items divided into 3 subscales: Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing upright Stiffness (2 items): after first waking and later in the day Physical Function (17 items): using stairs, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy domestic duties, light domestic duties The scores for each subscale are summed up, with a possible score range of 0-20 for pain, 0-8 for stiffness, and 0-68 for physical function. A higher score indicates a worse clinical outcome. Womac pain score is reported here.

  10 years

• 10 Year Survivorship

  Calculated Kaplan-Meier Survivorship based on revision of any component for any reason. Presented as the % of participants with the implant still in place 10 years post-operative.

  10 years post-operative

Secondary Outcomes (1)

• Oxford Hip Score

  10 years

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Male and Female ≥18 years

You may qualify if:

• Patients who are capable of understanding the doctor's explanations, following his instructions and are able to participate in the follow-up program
• Patient who gave verbal consent to take part in the study at study commencement and written consent retrospectively at 10 years follow-up by signing the informed consent form according to the General data protection Regulation (GDPR) Patient Consent Form"
• Age: =\> 18 years
• Male and Female
• Non- inflammatory degenerative joint disease including osteoarthritis, avascular necrosis \& post traumatic arthritis
• Rheumatoid arthritis,
• Correction of functional deformity
• Revision of failed joint reconstruction or treatment
• Treatment of femoral neck and trochanteric fractures of the proximal femur with femoral head involvement and which are unmanageable using other techniques

You may not qualify if:

• Infection, sepsis, and osteomyelitis
• Patients who are unwilling or unable to give consent, or to comply with the follow-up program
• The patient is known to be pregnant or breastfeeding
• Any vulnerable subjects (= individuals whose willingness to volunteer in a clinical investigation could be unduly influenced by the expectation, whether justified or not, of benefits associated with participation or of retaliatory response from senior members of a hierarchy in case of refusal to participate)
• Uncooperative patient or patient with neurologic disorders who are incapable of fol-lowing instruction
• Osteoporosis
• Metabolic disorder which may impair bone formation
• Osteomalacia
• Local and distant foci of infection
• Rapid joint destruction, marked bone loss or bone resorption apparent on roent-genogram
• Vascular insufficiency, muscular atrophy, or neuromuscular disease
• Skeletal immaturity
• Morbid obesity
• Foreign body sensitivity. Where suspected, material sensitivity tests are to be made prior to implantation
• Any condition that may interfere with the survival of the implant such as Paget's disease, Charcot's disease, sickle cell anaemia or traits, lower extremity muscular atrophy or neuromuscular disease'

Sponsors & Collaborators

• Zimmer Biomet: lead

MeSH Terms

Conditions

Osteoarthritis; Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

Arthritis; Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Limitations and Caveats

Initial CRF in the study did not record if an adverse event was serious yes/no. Where unknown, the event is recorded as serious.

Results Point of Contact

• Title: Linda Meijer
• Organization: Zimmer Biomet

linda.meijer@zimmerbiomet.com

+31627933741

Publication Agreements

• PI is Sponsor Employee: No
• Restrictive Agreement: No

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 28, 2020
• First Posted: February 5, 2020
• Study Start: July 1, 2010
• Primary Completion: February 28, 2022
• Study Completion: March 31, 2022
• Last Updated: July 26, 2024
• Results First Posted: July 26, 2024

Record last verified: 2024-02